Latest
Leading the Future of Cholangiocarcinoma Care—Because No One Else Will
Landmark Event: Leading experts & patient advocates united for the largest-ever event on cholangiocarcinoma treatment standardisation in Australia, driving innovation & action.
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
The TOPAZ-1 trial evaluated durvalumab plus chemotherapy for patients with advanced biliary tract cancer